QQ客服 官方微博 反馈留言

	Exploiting antitumor immunity to overcome relapse and improve remission duration
	Chen, Lei L.; Chen, Xinjian; Choi, Haesun; Sang, Hongxun; Chen, Leo C.; Zhang, Hongbo; Gouw, Launce; Andtbacka, Robert H.; Chan, Benjamin K.; Rodesch, Christopher K.
刊名	CANCER IMMUNOLOGY IMMUNOTHERAPY
	2012
卷号	61期号:[db:dc_citation_issue]页码:1113-1124
关键词	Peginterferon alpha-2b GIST IFN-alpha Immunotherapy IFN-gamma Imatinib
ISSN号	0340-7004
DOI	[db:dc_identifier_doi]
URL标识	查看原文
WOS记录号	[DB:DC_IDENTIFIER_WOSID]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4477714
专题	西安交通大学
推荐引用方式 GB/T 7714	Chen, Lei L.,Chen, Xinjian,Choi, Haesun,et al. Exploiting antitumor immunity to overcome relapse and improve remission duration[J]. CANCER IMMUNOLOGY IMMUNOTHERAPY,2012,61([db:dc_citation_issue]):1113-1124.
APA	Chen, Lei L..,Chen, Xinjian.,Choi, Haesun.,Sang, Hongxun.,Chen, Leo C..,...&Benjamin, Robert S..(2012).Exploiting antitumor immunity to overcome relapse and improve remission duration.CANCER IMMUNOLOGY IMMUNOTHERAPY,61([db:dc_citation_issue]),1113-1124.
MLA	Chen, Lei L.,et al."Exploiting antitumor immunity to overcome relapse and improve remission duration".CANCER IMMUNOLOGY IMMUNOTHERAPY 61.[db:dc_citation_issue](2012):1113-1124.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。